Roche immunoassay B-type natriuretic peptide precursor assay second generation - Taiwan Registration 076771454884a304ece989a8a827d3e6
Access comprehensive regulatory information for Roche immunoassay B-type natriuretic peptide precursor assay second generation in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 076771454884a304ece989a8a827d3e6 and manufactured by ROCHE DIAGNOSTICS GMBH. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including ROCHE DIAGNOSTICS GMBH, and 2 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is suitable for Elecsys 2010, MODULAR ANALYTICS E170, COBAS e 411/601/602 immunoassay, using electrochemiluminescence immunoassay (ECLIA) to quantitatively detect N-terminal pro B-type natriuretic peptide (NT-proBNP) in human serum and plasma.
A Clinical chemistry and clinical toxicology
A.1150 ๆ กๆญฃๅ;; A.1117 Bๅๅฉๅฐฟ้่ฝ่ฉฆ้ฉ็ณป็ตฑ
import
Dates and Status
Jul 24, 2013
Jul 24, 2023
Roche immunoassay B-type natriuretic peptide precursor assay second generation
ROCHE DIAGNOSTICS GMBH
22165506de2ee178ed749b298fc609c9
2
Roche immunoassay B-type natriuretic peptide precursor assay second generation
ROCHE DIAGNOSTICS GMBH
a34db0bb5334685489e9087e1e180dde
2

